Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate-treated mice

British Journal of Nutrition

Volumn 106, Issue 4, 2011, Pages 519-529

  Jia, Qian ^a   Ivanov, Ivan ^a,b   Zlatev, Zlatomir Z ^c   Alaniz, Robert C ^d   Eeks, Brad R ^b   Calla Ay, Evelyn S ^a   Goldsby, Jennifer S ^a   Davidson, Laurie A ^a   Fan, Yang Yi ^a   Zhou, Lan ^a   Lupton, Joanne R ^a   McMurray, David N ^a,d   Chapkin, Robert S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF SOFIA   (Bulgaria)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Colitis; Mucosal repair; Resolution of inflammation

Indexed keywords

CURCUMIN; DEXTRAN SULFATE; DRINKING WATER; FATTY ACID; FISH OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL KINETICS; CELL PROLIFERATION; COLON MUCOSA; CONTROLLED STUDY; DIETARY INTAKE; ENTERITIS; FATTY ACID ANALYSIS; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RNA ISOLATION; TISSUE MICROARRAY; UNINDEXED SEQUENCE;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; COLITIS; COLON; CURCUMIN; CYTOKINES; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; FISH OILS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTESTINAL MUCOSA; IRRITANTS; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RANDOM ALLOCATION; SURVIVAL ANALYSIS;

ANIMALIA; MUS; ZEA MAYS;

EID: 80052969788     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511000390     Document Type: Article

References (78)

1. Mudter J & Neurath MF (2003) Mucosal T cells: mediators or guardians of inflammatory bowel disease? Curr Opin Gastroenterol 19, 343-349. (Pubitemid 36819787)
2. Yamamoto-Furusho JK & Podolsky DK (2007) Innate immunity in inflammatory bowel disease. World J Gastroenterol 13, 5577-5580. (Pubitemid 350031477)
3. Rubin DT & Kavitt RT (2006) Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin North Am 35, 581-604. (Pubitemid 44307574)
4. Davidson LA, Nguyen DV, Hokanson RM, et al. (2004) Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 64, 6797-6804. (Pubitemid 39297944)
5. Prescott SM & Stenson WF (2005) Fish oil fix. Nature Med 11, 596-598. (Pubitemid 40868295)
6. Hudert CA, Weylandt KH, Lu Y, et al. (2006) Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci USA 103, 11276-11281. (Pubitemid 44156509)
7. Chang WC, Chapkin RS & Lupton JR (1997) Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 18, 721-730. (Pubitemid 28132459)
8. Whelan J & McEntee MF (2004) Dietary (n-6) PUFA and intestinal tumorigenesis. J Nutr 134, 3421S-3426S. (Pubitemid 39587584)
9. Nowak J, Weylandt KH, Habbel P, et al. (2007) Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids. Carcinogenesis 28, 1991-1995. (Pubitemid 47500613)
10. Hollenbach E, Vieth M, Roessner A, et al. (2005) Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn's disease. J Biol Chem 280, 14981-14988. (Pubitemid 40562850)
11. Waetzig GH, Seegert D, Rosenstiel P, et al. (2002) p38 Mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 168, 5342-5351. (Pubitemid 34496003)
12. Karrasch T & Jobin C (2008) NF-kappaB and the intestine: friend or foe? Inflamm Bowel Dis 14, 114-124.
13. Steinbrecher KA, Harmel-Laws E, Sitcheran R, et al. (2008) Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation. J Immunol 180, 2588-2599.
14. Duvoix A, Blasius R, Delhalle S, et al. (2005) Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223, 181-190. (Pubitemid 40719616)
15. Deguchi Y, Andoh A, Inatomi O, et al. (2007) Curcumin prevents the development of dextran sulfate sodium (DSS)-induced experimental colitis. Dig Dis Sci 52, 2993-2938.
16. Jian YT, Mai GF, Wang JD, et al. (2005) Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 11, 1747-1752.
17. Camacho-Barquero L, Villegas I, Sánchez-Calvo JM, et al. (2007) Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 7, 333-342. (Pubitemid 46186172)
18. Bharti AC, Donato N, Singh S, et al. (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053-1062. (Pubitemid 36139379)
19. Milacic V, Banerjee S, Landis-Piwowar KR, et al. (2008) Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res 68, 7283-7292.
20. Seril DN, Liao J, Yang GY, et al. (2003) Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24, 3533-3562.
21. Xiao H, Gulen MF, Qin J, et al. (2007) The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26, 461-475. (Pubitemid 46602997)
22. Hanai H & Sugimoto K (2009) Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des 15, 2087-2094.
23. Jia Q, Lupton JR, Smith R, et al. (2008) Reduced colitisassociated colon cancer in fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res 68, 3985-3991.
24. Hong MY, Bancroft LK, Turner ND, et al. (2005) Fish oil decreases oxidative DNA damage by enhancing apoptosis in rat colon. Nutr Cancer 52, 166-175. (Pubitemid 41579759)
25. Ma DW, Finnell RH, Davidson LA, et al. (2005) Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res 65, 887-897. (Pubitemid 40216448)
26. Kim W, Fan YY, Smith R, et al. (2009) Dietary curcumin and limonin suppress CD4\+ T-cell proliferation and interleukin-2 production in mice. J Nutr 139, 1042-1048.
27. Zlatev ZZ (2009) zRMicroArray: a computational environment for analyses of gene expression. Masters Thesis, Sofia University, Bulgaria.
28. Strimmer K (2008) A unified approach to false discovery rate estimation. BMC Bioinformatics 9, 303.
29. Okamoto R & Watanabe M (2005) Cellular and molecular mechanisms of the epithelial repair in IBD. Dig Dis Sci 50, Suppl. 1, S34-S38. (Pubitemid 41380796)
30. Le Jan S, Le Meur N, Cazes A, et al. (2006) Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer. FEBS Lett 580, 3395-3400. (Pubitemid 43795919)
31. Kingsbury GA, Feeney LA, Nong Y, et al. (2001) Cloning, expression, and function of BLAME, a novel member of the CD2 family. J Immunol 166, 5675-5680. (Pubitemid 32374191)
32. Baker BJ, Akhtar LN & Benveniste EN (2009) SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol 30, 392-400.
33. Patel S & Player MR (2009) Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease. Curr Top Med Chem 9, 599-610.
34. Ducut Sigala JL, Bottero V, Young DB, et al. (2004) Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science 304, 1963-1967. (Pubitemid 38822188)
35. Smith PG, Wilkinson KN, Savage KJ, et al. (2005) The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse B-cell lymphoma. Blood 105, 308-316. (Pubitemid 40053098)
36. Zhang R, Maratos-Flier E & Flier JS (2009) Reduced adiposity and high-fat diet-induced adipose inflammation in mice deficient for phosphodiesterase 4B. Endocrinology 150, 3076-3082.
37. Bollrath J, Phesse TJ, von Burstin VA, et al. (2009) gp130-Mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15, 91-102.
38. Grivennikov S, Karin E, Terzic J, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103-113.
39. Schraml BU, Hildner K, Ise W, et al. (2009) The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 460, 405-409.
40. Kanazawa S, Tsunoda T, Onuma E, et al. (2001) VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 96, 822-828. (Pubitemid 32240738)
41. Balla B, Kósa JP, Kiss J, et al. (2009) Transcriptional profiling of immune system-related genes in postmenopausal osteoporotic versus non-osteoporotic human bone tissue. Clin Immunol 131, 354-359.
42. Wilson MD, Cheung J, Martindale DW, et al. (2006) Comparative analysis of the paired immunoglobulin-like receptor (PILR) locus in six mammalian genomes: duplication, conversion, and the birth of new genes. Physiol Genomics 27, 201-218. (Pubitemid 46711005)
43. Tai LH, Goulet ML, Belanger S, et al. (2008) Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J Exp Med 205, 3187-3199.
44. Funayama H, Huang L, Asada Y, et al. (2010) Enhanced induction of a histamine-forming enzyme, histidine hecarboxylase, in mice primed with nod1 or nod2 ligand in response to various toll-like receptor agonists. Innate Immun 16, 265-272.
45. Buac K, Xu M, Cronin J, et al. (2009) NRG1/ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation. Pigment Cell Melanoma Res 22, 773-784.
46. Zou XH, Jiang YZ, Zhang GR, et al. (2009) Specific interactions between human fibroblasts and particular chondroitin sulfate molecules for wound healing. Acta Biomater 5, 1588-1595.
47. Offenhäuser N, Borgonovo A, Disanza A, et al. (2004) The eps8 family of proteins links growth factor stimulation to actin reorganization generating functional redundancy in the Ras/Rac pathway. Mol Biol Cell 15, 91-98. (Pubitemid 38044946)
48. Chapkin RS, McMurray DN & Lupton JR (2007) Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 23, 48-54. (Pubitemid 44875910)
49. Hatcher H, Planalp R, Cho J, et al. (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65, 1631-1652.
50. Weaver KL, Ivester P, Seeds M, et al. (2009) Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J Biol Chem 284, 15400-15407.
51. Gurtner GC, Werner S, Barrandon Y, et al. (2008) Wound repair and regeneration. Nature 453, 314-321. (Pubitemid 351693137)
52. Blikslager AT, Moeser AJ, Gookin JL, et al. (2007) Restoration of barrier function in injured intestinal mucosa. Physiol Rev 87, 545-564. (Pubitemid 47084680)
53. Barrientos S, Stojadinovic O, Golinko MS, et al. (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16, 585-601.
54. Rakoff-Nahoum S & Medzhitov R (2007) Prostaglandinsecreting cells: a portable first aid kit for tissue repair. J Clin Invest 117, 83-86. (Pubitemid 46048453)
55. Chapkin RS, Kim W, Lupton JR, et al. (2009) Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 81, 187-191.
56. Koeberle A, Northoff H & Werz O (2009) Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1. Mol Cancer Ther 8, 2348-2355.
57. Chakravarti N, Myers JN & Aggarwal BB (2006) Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int J Cancer 119, 1268-1275. (Pubitemid 44258799)
58. Courtney ED, Matthews S, Finlayson C, et al. (2007) Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 22, 765-776. (Pubitemid 46863753)
59. Fukata M, Michelsen KS, Eri R, et al. (2005) Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288, G1055-G1065. (Pubitemid 40563149)
60. Fukata M, Chen A, Klepper A, et al. (2006) Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131, 862-877. (Pubitemid 44316821)
61. Rakoff-Nahoum S & Medzhitov R (2009) Toll-like receptors and cancer. Nat Rev Cancer 9, 57-63.
62. Wong SW, Kwon MJ, Choi AM, et al. (2009) Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a ros-dependent manner. J Biol Chem 284, 27384-27392.
63. Huang S, Zhao L, Kim K, et al. (2008) Inhibition of Nod2 signaling and target gene expression by curcumin. Mol Pharmacol 74, 274-281. (Pubitemid 351872178)
64. Lee DY, Lupton JR, Aukema HM, et al. (1993) Dietary fat and fiber alter rat colonic mucosal lipid mediators and cell proliferation. J Nutr 123, 1808-1817. (Pubitemid 23342475)
65. Buchanan FG & DuBois RN (2006) Connecting COX-2 and Wnt in cancer. Cancer Cell 9, 6-8. (Pubitemid 43069505)
66. Hatazawa R, Tanaka A, Tanigami M, et al. (2007) Cyclooxygenase-2/ prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. Am J Physiol Gastrointest Liver Physiol 293, G788-G797. (Pubitemid 47605917)
67. Ungaro R, Fukata M, Hsu D, et al. (2009) A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol 296, G1167-G1179.
68. Fan YY, Ly LH, Barhoumi R, et al. (2004) Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J Immunol 173, 6151-6160. (Pubitemid 39487772)
69. Aggarwal S, Ichikawa H, Takada Y, et al. (2006) Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69, 195-206. (Pubitemid 43048906)
70. Nishihara M, Ogura H, Ueda N, et al. (2007) IL-6-gp130-STAT3 in T cells directs the development of IL-17 \+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 19, 695-702. (Pubitemid 47078714)
71. Wu S, Rhee KJ, Albesiano E, et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15, 1016-1022.
72. Kortylewski M, Xin H, Kujawski M, et al. (2009) Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15, 114-123.
73. Bouwens M, van de Rest O, Dellschaft N, et al. (2009) Fishoil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 90, 415-424.
74. Farzaneh-Far R, Harris WS, Garg S, et al. (2009) Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 205, 538-543.
75. Mähler M, Bristol IJ, Leiter EH, et al. (1998) Differential susceptibility of inbred mouse strains to dextran sulfate sodiuminduced colitis. Am J Physiol 274, 3 Pt 1, G544-G551.
76. Suzuki R, Kohno H, Sugie S, et al. (2006) Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 27, 162-169. (Pubitemid 43025257)
77. Melgar S, Karlsson A & Michaëlsson E (2005) Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 288, G1328-G1338. (Pubitemid 40741088)
78. Uchiyama K, Nakamura M, Odahara S, et al. (2010) n-3 Polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. Inflamm Bowel Dis 16, 1696-1701.